Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Cipla
Novartis
McKinsey
Deloitte
Farmers Insurance
Moodys
Accenture
Colorcon
AstraZeneca

Generated: October 20, 2017

DrugPatentWatch Database Preview

PROPULSID Drug Profile

« Back to Dashboard

Which patents cover Propulsid, and what generic Propulsid alternatives are available?

Propulsid is a drug marketed by Janssen Pharms and Janssen Pharma and is included in three NDAs.

The generic ingredient in PROPULSID is cisapride monohydrate. There are two drug master file entries for this compound. Additional details are available on the cisapride monohydrate profile page.

Summary for Tradename: PROPULSID

US Patents:0
Applicants:2
NDAs:3
Bulk Api Vendors: see list29
Clinical Trials: see list1
Patent Applications: see list111
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROPULSID at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms
PROPULSID
cisapride monohydrate
TABLET;ORAL020210-001Jul 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Janssen Pharma
PROPULSID QUICKSOLV
cisapride monohydrate
TABLET, ORALLY DISINTEGRATING;ORAL020767-001Nov 7, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Janssen Pharms
PROPULSID
cisapride monohydrate
TABLET;ORAL020210-002Dec 23, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Janssen Pharms
PROPULSID
cisapride monohydrate
SUSPENSION;ORAL020398-001Sep 15, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROPULSID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
PROPULSID
cisapride monohydrate
TABLET;ORAL020210-001Jul 29, 1993► Subscribe► Subscribe
Janssen Pharms
PROPULSID
cisapride monohydrate
SUSPENSION;ORAL020398-001Sep 15, 1995► Subscribe► Subscribe
Janssen Pharms
PROPULSID
cisapride monohydrate
TABLET;ORAL020210-002Dec 23, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Cipla
McKesson
Harvard Business School
Farmers Insurance
Citi
UBS
Colorcon
Dow
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot